NEW YORK, Sept. 1, 2020 /PRNewswire/ --
Report Scope:
This report examines the current and future market potential of capnography devices.It offers a detailed analysis of the competitive environment, regulatory scenario, technological advancement, drivers and restraints, and opportunity and trends in market growth.
Read the full report: https://www.reportlinker.com/p05955174/?utm_source=PRN
The report also covers market projections to 2024 and market shares for key market players. The capnography devices market is broken down by products, technologies, applications and end users.
This report segments the global market by these geographical regions: North America, Europe, Asia-Pacific and the Rest of the world. The North America region includes the U.S., Canada and Mexico; Europe includes Germany, U.K., France and Rest of Europe; the Asia-Pacific region includes China, India, Japan and Rest of Asia-Pacific. For market estimates, data are provided for 2018 as the base year and 2019 and forecast through 2024.
Report Includes:
- 24 data tables and 15 additional tables
- An overview of the global capnography devices markets
- Analyses of market trends, with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Market share analysis of capnography devices based on types of product, application and end users
- Discussion on impact of COVID-19 on the capnography devices markets, MedTech and medical tourism
- Evaluation of current market trends, market size, market forecast, pipeline analysis of new devices, and regulatory and reimbursement scenarios
- Coverage of global confirmed COVID-19 cases and deaths and a look at the collaboration between organizations and governments to stop this pandemic and details of regulatory delays, clinical trials, and new product launches in the industry
- Market share analysis of the key companies of the industry, their strategic profiling, competitive landscape, and their detailed company profiles, including Drägerwerk AG & Co. KGaA, Infinium Medical, Medtronic PLC, Philips, Nihon Kohden Corp. and Smiths Medical
Summary:
The global market for capnography deviceswas valued at REDACTED in 2018. The market is forecast to grow at a compound annual growth rate (CAGR) of REDACTED to reach approximately REDACTED by 2024.
Reasons for Doing This Study
The capnogram is a direct monitor of the CO2 concentration inhaled and exhaled.Capnography is the monitoring and measuring of the partial pressure of carbon dioxide (CO2) in the respiratory gases.
It is mostly developed and used as a monitoring tool during anesthesia and intensive care. A graph of expiratory CO2 (measured in millimeters of mercury, "mmHg") plotted against time may show the Inhaled CO2, which is of concern when rebreathing systems are used.
Capnographs work on the principle that CO2 is absorbed by infrared radiation.In a capnograph, a beam of infrared light is passed across the gas sample to fall on a sensor.
The presence of CO2 in the gas leads to a reduction in the amount of light falling on the sensor, which changes the voltage in a circuit.The analysis is quick and precise, but the existence of nitrous oxide in the gas mixture changes the infrared absorption.
This phenomenon is called collision broadening. However, this must be corrected for measuring the CO2 in human breath.
Major factors driving this market globally include the development of portable/point-of-care capnography devices, clinical benefits of capnography equipment over pulse oximetry, evolving guidelines related to the clinical use of capnography, increasing number of surgeries, and the rapid growth in the geriatric population.There is also increased availability of clinical evidence to support capnography monitoring.
Emerging markets are also posing growth opportunities during the forecast period.
The novel coronavirus, SARS-COV-2, is an infectious disease which causes COVID-19.Most people with COVID-19 will experience mild to moderate respiratory illness.
Older people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease and cancer are more likely to develop serious illness.In severe cases, the virus triggers damage to the lungs, causing the body's oxygen levels to decline and making it difficult to breathe.
Increasing COVID-19 cases globally are slowing down the production of various medical devices.
Read the full report: https://www.reportlinker.com/p05955174/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article